Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancer

Cancer immunology research

Volumn 2, Issue 12, 2014, Pages 1154-1162

  Kibe, Shiro ^a   Yutani, Shigeru ^a   Motoyama, Satoru ^a   Nomura, Takanobu ^a   Tanaka, Natsuki ^a   Kawahara, Akihiko ^a   Yamaguchi, Tomohiko ^a   Matsueda, Satoko ^a   Komatsu, Nobukazu ^a   Miura, Masatomo ^a   Hinai, Yudai ^a   Hattori, Satoshi ^a   Yamada, Akira ^a   Kage, Masayoshi ^a   Itoh, Kyogo ^a   Akagi, Yoshito ^a   Sasada, Tetsuro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CANCER VACCINE; HISTOCOMPATIBILITY ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; SUBUNIT VACCINE;

ADULT; AGED; CANCER STAGING; CLINICAL TRIAL; COLORECTAL NEOPLASMS; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; IMMUNOTHERAPY; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PERSONALIZED MEDICINE; PHASE 2 CLINICAL TRIAL; RETREATMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CANCER VACCINES; COLORECTAL NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INDIVIDUALIZED MEDICINE; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-6; RETREATMENT; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME; VACCINES, SUBUNIT;

EID: 84937511676     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0035     Document Type: Article

References (0)